Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.
Fares J, Petrosyan E, Kanojia D, Dmello C, Cordero A, Duffy JT, Yeeravalli R, Sahani MH, Zhang P, Rashidi A, Arrieta VA, Ulasov I, Ahmed AU, Miska J, Balyasnikova IV, James CD, Sonabend AM, Heimberger AB, Lesniak MS.
Fares J, et al. Among authors: duffy jt.
J Clin Invest. 2023 Dec 15;133(24):e161142. doi: 10.1172/JCI161142.
J Clin Invest. 2023.
PMID: 37847564
Free PMC article.